Charles River Laboratories International ($CRL) Insider Trading & Smart Money Activity
Charles River Laboratories International, Inc. ($CRL) has 2 insider trades, 3 13F position changes and 9 analyst ratings on file. In the last 12 months on the open market, 1 insider bought ($2.97K) and 1 insider sold ($302.58K), net -$299.61K.
- Insider buyers (12 mo)
- 1
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$299.61K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 3
- Analyst ratings on file
- 9
CRL insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 2 / 1 |
| Q3 2026 | 1 · $2.97K | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 1 · $302.58K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CRL insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | Morgan Stanley | Reiterates to Overweight | PT $340 | Read | |||||||
| Insider | Parisotto Shannon MCEVP, Disc & Safety Assessment | Sell (Open-market sale) 10b5-1 | 981 sh | $302.58K | -2.9% | — | |||||
| Insider | Coleman GlennEVP & Chief Financial Officer | Buy (Open-market buy) | 10 sh | $2.97K | +1.8% | — | |||||
| Analyst | Jefferies | Reiterates to Buy | PT $340 | +5.5% | — | ||||||
| Analyst | TD Cowen | Reiterates to Buy | PT $325 | -0.9% | — | ||||||
| Analyst | RBC Capital | Reiterates to Outperform | PT $322 | -0.9% | — | ||||||
| Analyst | Evercore ISI Group | Reiterates to Outperform | PT $330 | -0.9% | — | ||||||
| Analyst | Deutsche Bank | Reiterates to Buy | PT $320 | -0.9% | — | ||||||
| Analyst | Barclays | Reiterates to Overweight | PT $330 | -0.9% | — | ||||||
| Analyst | Baird | Reiterates to Outperform | PT $334 | -0.9% | — | ||||||
| Analyst | Morgan Stanley | Raises to buy | PT $220 | +10.8% | +23.0% | Read | |||||
| 13F | Gotham Asset Management | Added | +68.99K sh | $67.42M | +6.3% | +24.9% | Read | ||||
| 13F | Gotham Asset Management | Added | +68.99K sh | $81.30M | +6.3% | +24.9% | — | ||||
| 13F | Earnest Partners | Reduced | -16.89K sh | $220.30M | +6.3% | +24.9% | Read |
1W / 1M / 6M = how CRL moved from the trade or filing date.
Insider trading in CRL: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Parisotto Shannon M | CEVP, Disc & Safety Assessment | 1 | -$302.58K | Oct 5, 2026 | |
| Coleman Glenn | EVP & Chief Financial Officer | 1 | +$2.97K | Sep 30, 2026 |
Institutions moving CRL (13F)
Analyst ratings on CRL
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | Reiterates | Overweight | $300 → $340 | Read | ||||
| Jefferies | Reiterates | Buy | $305 → $340 | +5.5% | — | |||
| TD Cowen | Reiterates | Buy | $300 → $325 | -0.9% | — | |||
| RBC Capital | Reiterates | Outperform | $282 → $322 | -0.9% | — | |||
| Evercore ISI Group | Reiterates | Outperform | $320 → $330 | -0.9% | — | |||
| Deutsche Bank | Reiterates | Buy | $300 → $320 | -0.9% | — | |||
| Barclays | Reiterates | Overweight | $300 → $330 | -0.9% | — | |||
| Baird | Reiterates | Outperform | $291 → $334 | -0.9% | — | |||
| Morgan Stanley | Raises | buy | $220 | +10.8% | +23.0% | Read |
Frequently asked questions
Are CRL insiders buying or selling?
Over the last 12 months 1 insider made 1 open-market purchase worth $2.97K and 1 insider made 1 open-market sale worth $302.58K, a net -$299.61K.
What is the latest insider trade in CRL?
Parisotto Shannon M, CEVP, Disc & Safety Assessment filed a sell (open-market sale) of 981 sh worth $302.58K on Oct 5, 2026.
Which institutions changed their CRL positions?
Recent 13F filers moving the stock include Gotham Asset Management and Earnest Partners.
Other diagnostics & research stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.